USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	064576/0500			Pages:	8
		Recorded:	08/14/2023
Attorney Dkt #:	34108-00002
Conveyance:	CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED AT REEL: 057326 FRAME: 0322. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.

Total properties: 25

Patent #:	11369760	Issue Dt:	06/28/2022	Application #:	15658431	Filing Dt:	07/25/2017
Publication #:	US20190030268	Pub Dt:	01/31/2019
Title:	Inhalation Atomizer Comprising a Blocking Function and a Counter

Patent #:	NONE	Issue Dt:		Application #:	16837499	Filing Dt:	04/01/2020
Publication #:	US20200324064	Pub Dt:	10/15/2020
Title:	Inhalation Device for Administering Powdered Pharmaceutical Composition

Patent #:	11642333	Issue Dt:	05/09/2023	Application #:	16881354	Filing Dt:	05/22/2020
Publication #:	US20200368214	Pub Dt:	11/26/2020
Title:	INHALABLE FORMULATION OF A SOLUTION CONTAINING VILANTEROL TRIFENATATE AND UMECLIDINIUM BROMIDE

Patent #:	NONE	Issue Dt:		Application #:	16890528	Filing Dt:	06/02/2020
Publication #:	US20200375945	Pub Dt:	12/03/2020
Title:	INHALABLE FORMULATION OF A SOLUTION CONTAINING INDACATEROL MALEATE AND GLYCOPYRRONIUM BROMIDE

Patent #:	NONE	Issue Dt:		Application #:	16910860	Filing Dt:	06/24/2020
Publication #:	US20200405700	Pub Dt:	12/31/2020
Title:	INHALABLE FORMULATION OF A SOLUTION CONTAINING FORMOTEROL FUMARATE AND ACLIDINIUM BROMIDE

Patent #:	NONE	Issue Dt:		Application #:	16941974	Filing Dt:	07/29/2020
Publication #:	US20210030978	Pub Dt:	02/04/2021
Title:	CARTRIDGE WITH SINGLE-LAYER CONTAINER AND ITS NOZZLE-SHAPED CAP FOR NEBULIZATION INHALATION

Patent #:	NONE	Issue Dt:		Application #:	16942339	Filing Dt:	07/29/2020
Publication #:	US20210030868	Pub Dt:	02/04/2021
Title:	FORMULATION OF ANTIBODY BASED DRUGS FOR TREATING LUNG CANCER BY INHALATION

Patent #:	11304901	Issue Dt:	04/19/2022	Application #:	17001889	Filing Dt:	08/25/2020
Publication #:	US20210059937	Pub Dt:	03/04/2021
Title:	Liposome Formulation of Fluticasone Furoate and Method of Preparation

Patent #:	NONE	Issue Dt:		Application #:	17137559	Filing Dt:	12/30/2020
Publication #:	US20210205223	Pub Dt:	07/08/2021
Title:	PROPELLANT-FREE FORMULATION FOR INHALATION

Patent #:	11083693	Issue Dt:	08/10/2021	Application #:	17151790	Filing Dt:	01/19/2021
Publication #:	US20210220275	Pub Dt:	07/22/2021
Title:	LIPOSOME FORMULATION OF VILANTEROL TRIFENATATE

Patent #:	NONE	Issue Dt:		Application #:	17152049	Filing Dt:	01/19/2021
Publication #:	US20210220367	Pub Dt:	07/22/2021
Title:	INHALABLE FORMULATION OF A SOLUTION CONTAINING GLYCOPYRROLATE AND OLODATEROL HYDROCHLORIDE

Patent #:	NONE	Issue Dt:		Application #:	17168262	Filing Dt:	02/05/2021
Publication #:	US20210252027	Pub Dt:	08/19/2021
Title:	PHARMACEUTICAL FORMULATION CONTAINING REMDESIVIR

Patent #:	NONE	Issue Dt:		Application #:	17205660	Filing Dt:	03/18/2021
Publication #:	US20210290568	Pub Dt:	09/23/2021
Title:	INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL TARTRATE

Patent #:	NONE	Issue Dt:		Application #:	17231727	Filing Dt:	04/15/2021
Publication #:	US20210322309	Pub Dt:	10/21/2021
Title:	Inhalable Formulation of a Solution Containing Olodaterol

Patent #:	NONE	Issue Dt:		Application #:	17231821	Filing Dt:	04/15/2021
Publication #:	US20210322311	Pub Dt:	10/21/2021
Title:	Inhalable Formulation of a Solution Containing Tiotropium Bromide and Olodaterol

Patent #:	NONE	Issue Dt:		Application #:	17316933	Filing Dt:	05/11/2021
Publication #:	US20210346288	Pub Dt:	11/11/2021
Title:	PHARMACEUTICAL FORMULATION CONTAINING ACTIVE METABOLITES OF REMDESIVIR FOR INHALATION

Patent #:	NONE	Issue Dt:		Application #:	17323109	Filing Dt:	05/18/2021
Publication #:	US20210353650	Pub Dt:	11/18/2021
Title:	PHARMACEUTICAL FORMULATION CONTAINING REMDESIVIR AND ITS ACTIVE METABOLITES FOR DRY POWDER INHALATION

Patent #:	11304897	Issue Dt:	04/19/2022	Application #:	17342781	Filing Dt:	06/09/2021
Publication #:	US20210378955	Pub Dt:	12/09/2021
Title:	PHARMACEUTICAL FORMULATION CONTAINING UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Patent #:	NONE	Issue Dt:		Application #:	17342859	Filing Dt:	06/09/2021
Publication #:	US20210386730	Pub Dt:	12/16/2021
Title:	PHARMACEUTICAL FORMULATION CONTAINING GLYCOPYRROLATE AND INDACATEROL MALEATE

Patent #:	NONE	Issue Dt:		Application #:	17354140	Filing Dt:	06/22/2021
Publication #:	US20220031712	Pub Dt:	02/03/2022
Title:	PREPARATION OF A PHARMACEUTICAL COMPOSITION OF OLODATEROL AND BUDESONIDE

Patent #:	NONE	Issue Dt:		Application #:	17354345	Filing Dt:	06/22/2021
Publication #:	US20210393521	Pub Dt:	12/23/2021
Title:	PREPARATION OF A PHARMACEUTICAL COMPOSITION OF OLODATEROL, TIOTROPIUM BROMIDE AND BUDESONIDE

Patent #:	NONE	Issue Dt:		Application #:	17354702	Filing Dt:	06/22/2021
Publication #:	US20210393663	Pub Dt:	12/23/2021
Title:	PHARMACEUTICAL FORMULATION CONTAINING ACTIVE METABOLITES OF REMDESIVIR OR ITS ANALOG FOR INHALATION

Patent #:	NONE	Issue Dt:		Application #:	17361471	Filing Dt:	06/29/2021
Publication #:	US20210401855	Pub Dt:	12/30/2021
Title:	PHARMACEUTICAL FORMULATION CONTAINING COMBINATION OF M3 ANTAGONIST-BETA-2 AGONIST AND INHALED CORTICOSTEROIDS

Patent #:	11365248	Issue Dt:	06/21/2022	Application #:	17361651	Filing Dt:	06/29/2021
Publication #:	US20210403550	Pub Dt:	12/30/2021
Title:	FORMULATION OF TOCILIZUMAB AND METHOD FOR TREATING COVID-19 BY INHALATION

Patent #:	NONE	Issue Dt:		Application #:	17362218	Filing Dt:	06/29/2021
Publication #:	US20210403568	Pub Dt:	12/30/2021
Title:	BIOPHARMACEUTICAL FORMULATION OF ANTI-PD-1, ANTI-PD-L1, AND ANTI-VEGFR THERAPEUTIC MONOCLONAL ANTIBODIES AND METHOD FOR TREATING NSCLC BY INHALATION

Assignor

Exec Dt:

08/20/2021

Assignee

ONE GATEWAY CENTER

SUITE 2600

NEWARK, NEW JERSEY 07102

Correspondence name and address
	PARKER POE ADAMS & BERNSTEIN LLP
	1400 K STREET, NW
	SUITE 1000
	WASHINGTON, DC 20005

Search Results as of: 06/03/2024 11:41 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6